SCHEMBL8950208

SCHEMBL8950208

COCCN(CCOC)CC1=Cc2ccsc2S(=O)(=O)N1c1ccc(OC)cc1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950119 0.84 CMA1 (0.32)
SCHEMBL8950275 0.80 CA2 (0.53) CA2CA4
SCHEMBL9057290 0.75 NPC1 (0.32)
SCHEMBL9058416 0.69 POLB (0.35)
SCHEMBL8950341 0.65 CA2 (0.46) CA2CA4
SCHEMBL9117670 0.65
SCHEMBL9058135 0.63 CA2 (0.45) CA2CA4
SCHEMBL8950282 0.58 CA2 (0.49) CA2CA4
SCHEMBL8950251 0.58 CA2 (0.48) CA2CA4
SCHEMBL17230510 0.56 TSHR (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US disclosed